International regulatory uses of acute systemic toxicity data and integration of new approach methodologies
Authors:
- 9 August 2023
- journal article
- research article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 53 (7) , 385-411
Abstract
Chemical regulatory authorities around the world require systemic toxicity data from acute exposures via the oral, dermal, and inhalation routes for human health risk assessment. To identify opportunities for regulatory uses of non-animal replacements for these tests, we reviewed acute systemic toxicity testing requirements for jurisdictions that participate in the International Cooperation on Alternative Test Methods (ICATM): Brazil, Canada, China, the European Union, Japan, South Korea, Taiwan, and the USA. The chemical sectors included in our review of each jurisdiction were cosmetics, consumer products, industrial chemicals, pharmaceuticals, medical devices, and pesticides. We found acute systemic toxicity data were most often required for hazard assessment, classification, and labeling, and to a lesser extent quantitative risk assessment. Where animal methods were required, animal reduction methods were typically recommended. For many jurisdictions and chemical sectors, non-animal alternatives are not accepted, but several jurisdictions provide guidance to support the use of test waivers to reduce animal use for specific applications. An understanding of international regulatory requirements for acute systemic toxicity testing will inform ICATM's strategy for the development, acceptance, and implementation of non-animal alternatives to assess the health hazards and risks associated with acute toxicity.Keywords
Funding Information
- National Institute of Environmental Health Sciences
- National Institutes of Health (HHSN273201500010C)
- Inotiv, Inc
- National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods
- Carroll Petrie Foundation
- NIEHS
- National Institutes of Health (HHSN273201500010C)
This publication has 20 references indexed in Scilit:
- Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agenciesRegulatory Toxicology and Pharmacology, 2018
- An evaluation of the fixed concentration procedure for assessment of acute inhalation toxicityRegulatory Toxicology and Pharmacology, 2018
- Comment on “Alternative acute oral toxicity assessment under REACH based on sub-acute toxicity values”ALTEX, 2018
- Reply to Comment on “Alternative acute oral toxicity assessment under REACH based on sub-acute toxicity values”ALTEX, 2018
- Biometrical evaluation of the performance of the revised OECD Test Guideline 402 for assessing acute dermal toxicityRegulatory Toxicology and Pharmacology, 2017
- Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testingToxicology in Vitro, 2017
- Alternative acute oral toxicity assessment under REACH based on sub-acute toxicity valuesALTEX, 2017
- Act on the Registration and Evaluation of Chemicals (K-REACH) and replacement, reduction or refinement best practicesEnvironmental Health and Toxicology, 2016
- GHS additivity formula: A true replacement method for acute systemic toxicity testing of agrochemical formulationsRegulatory Toxicology and Pharmacology, 2016
- Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000mg/kg): Results of an ECVAM validation studyRegulatory Toxicology and Pharmacology, 2013